The sale of Zila's nutraceutical business to NBTY, including
Ester-C, has completed, marking the new owner's entry into
ingredients and freeing up the old owner's attention for its core
cancer detection interests.
Zila Nutraceuticals has developed and patented a new form of
Ester-C said to offer improved antioxidant and anti-carcinogenic
potential, which should allow it to maintain its advantage in the
vitamin C market until the end of next...